A Randomised Controlled Feasibility Trial of Surgery versus No Surgery as Part of Multi-Modality Treatment in Stage III-N2 Non-Small Cell Lung Cancer

被引：0

作者：

Taylor, Sally ^{[1
]}

Stanworth, Melissa ^{[1
]}

Ward, Ashleigh ^{[1
]}

Harris, Emily ^{[1
]}

Tsim, Selina ^{[2
]}

Navani, Neal ^{[3
]}

Baldwin, David ^{[4
]}

Woolhouse, Ian ^{[5
]}

Edwards, John ^{[6
]}

Grundy, Seamus ^{[7
]}

Rhodes, Sarah ^{[8
]}

Burnside, Nathan ^{[4
]}

Blackhall, Fiona ^{[1
]}

Faivre-Finn, Corinne ^{[1
]}

Yorke, Janelle ^{[1
]}

Evison, Matthew ^{[9
]}

机构：

[1] Christie NHS Fdn Trust, Manchester, Lancs, England

[2] Queen Elizabeth Univ Hosp, Glasgow, Lanark, Scotland

[3] Univ Coll London Hosp, London, England

[4] Nottingham Univ Hosp NHS Trust, Nottingham, England

[5] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England

[6] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England

[7] Salford Royal NHS Fdn Trust, Salford, Lancs, England

[8] Univ Manchester, Manchester, Lancs, England

[9] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England

来源：

LUNG CANCER | 2024年 / 190卷

关键词：

D O I：

10.1016/j.lungcan.2024.107698

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

137

引用

页数：2

共 50 条

[1] Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)
Taylor, Sally
Tsim, Selina
Navani, Neal
Baldwin, David
Woolhouse, Ian
Edwards, John
Grundy, Seamus
Robson, Jonathan
Rhodes, Sarah
Burnside, Nathan
Blackhall, Fiona
Faivre-Finn, Corinne
Yorke, Janelle
Evison, Matthew
LUNG CANCER, 2022, 165 : S69 - S69
[2] Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)
Taylor, Sally
Yorke, Janelle
Tsim, Selina
Navani, Neal
Baldwin, David
Woolhouse, Ian
Edwards, John
Grundy, Seamus
Robson, Jonathan
Rhodes, Sarah
Gomes, Fabio
Blackhall, Fiona
Faivre-Finn, Corinne
Evison, Matthew
BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)
[3] Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer
Pitz, CCM
Maas, KW
Van Swieten, HA
de la Rivière, AB
Hofman, P
Schramel, FMNH
ANNALS OF THORACIC SURGERY, 2002, 74 (01): : 164 - 169
[4] Multi-modality treatment of non-small cell lung cancer
Feins, RH
SURGICAL CLINICS OF NORTH AMERICA, 2002, 82 (03) : 611 - +
[5] DO PATIENTS COMMENCING MULTI-MODALITY TREATMENT FOR STAGE III-N2 LUNG CANCER COMPLETE THEIR TREATMENT?
Campbell, C.
Salman, R.
Morris, J.
Awni, H.
Paramasivam, E.
Kennedy, M. P. T.
THORAX, 2021, 76 : A97 - A97
[6] Role of surgery in multi-modality treatment for carcinomatous pleuritis in patients with non-small cell lung cancer
Go, Tetsuhiko
Misaki, Noriyuki
Matsuura, Natsumi
Chang, Sung Soo
Tarumi, Shintarou
Yokomise, Hiroyasu
SURGERY TODAY, 2015, 45 (02) : 197 - 202
[7] Role of surgery in multi-modality treatment for carcinomatous pleuritis in patients with non-small cell lung cancer
Tetsuhiko Go
Noriyuki Misaki
Natsumi Matsuura
Sung Soo Chang
Shintarou Tarumi
Hiroyasu Yokomise
Surgery Today, 2015, 45 : 197 - 202
[8] Multi-Modality Imaging of Treatment Response After Stage III Non-Small Cell Lung Cancer Radiotherapy
Young, H. M.
Chau, O.
Burgers, K.
Lee, T. Y.
Prato, F. S.
Wisenberg, G.
Gaede, S.
MEDICAL PHYSICS, 2020, 47 (06) : E640 - E641
[9] Trimodal Therapy of non-small cell Lung Cancer in Stage III-N2
Askoxylakis, V.
Tanner, J.
Nicolay, N.
Rief, H.
Bischof, M.
STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 91 - 91
[10] Surgery is a promising strategy for improving overall survival for stage III-N2 non-small cell lung cancer patients
Yang, Jie
Jiang, Chao
Wang, Yue
Qiu, Rong
Su, Jingwei
Liu, Changjiang
Jing, Li
JOURNAL OF THORACIC DISEASE, 2023, 15 (03) : 1426 - 1432

← 1 2 3 4 5 →